Attached files

file filename
EX-3.1 - EXHIBIT 3.1 - NeuroMetrix, Inc.v411741_ex3-1.htm

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

_______________________________

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

__________________________________

 

Date of Report (Date of earliest event reported): May 26, 2015

 

 

  NEUROMETRIX, INC.  

(Exact name of registrant as specified in charter)

 

Delaware

001-33351

04-3308180

(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer
Identification No.)

 

1000 Winter Street, Waltham, Massachusetts     02451
(Address of principal executive offices)                (Zip Code)

 

(781) 890-9989
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 3.03.Material Modification to Rights of Security Holders.

 

The information disclosed in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.

 

Item 5.03.Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On May 26, 2015, NeuroMetrix, Inc. (the “Company”) filed with the Delaware Secretary of State a Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, that created the Company’s new Series B Convertible Preferred Stock, designated 147,000 shares of the Company’s preferred stock as Series B Convertible Preferred Stock and designated the preferences, rights and limitations of the Series B Convertible Preferred Stock. The Series B Convertible Preferred Stock is non-voting (except to the extent required by law and except for certain consent rights relating to amending the certificate of designation), but ranks senior to the Company’s common stock with respect to distributions upon a deemed dissolution, liquidation or winding-up of the Company.

 

Item 9.01Exhibits

 

Exhibit Number   Description
 3.1  

 Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock, par value $0.001 per share

 

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

    NEUROMETRIX, INC.
   
   
Date: May 29, 2015   /s/ THOMAS T. HIGGINS  
    Thomas T. Higgins
    Senior Vice President, Chief Financial Officer
        and Treasurer